OBJECTIVE -To determine the relative roles of different modalities of sensory nerve function (large and small fiber) and the role of microvascular dysfunction in foot ulceration in type 2 diabetic subjects.
RESEARCH DESIGN AND METHODS-A total of 20 control subjects and 18 type 2 diabetic subjects with foot ulceration and 20 without were studied. None of the subjects had clinical features of peripheral vascular disease. The Computer-Aided Sensory Evaluator IV (CASE IV) was used to determine vibration detection threshold (VDT), cold detection threshold (CDT), warm detection threshold (WDT), and heat pain onset threshold (HPO). Vibration perception threshold (VPT) was also assessed by a neurothesiometer. Microvascular function (maximum hyperemia to skin heating to 44°C) was assessed using laser Doppler flowmetry (mean maximum hyperemia using laser Doppler flowmeter [LDF max ]), laser Doppler imaging (mean maximum hyperemia using laser Doppler imager [LDI max ]), and skin oxygenation with transcutaneous oxygen tension (TcpO 2 ).RESULTS -VPT, VDT, CDT, and HPO were all significantly higher in individuals with ulceration than in those without (VPT and VDT: P Ͻ 0.0001) (CDT and HPO: P ϭ 0.01). LDF max , LDI max , and TcpO 2 were significantly lower in the two diabetic groups than in the control subjects, but there was no difference between individuals with and without ulceration. CONCLUSIONS -This study found that there was no additional value in measuring smallfiber function with the CASE IV over measuring vibration by either CASE IV or the inexpensive neurothesiometer in discriminating between individuals with and without ulceration. Furthermore, none of the tests of microvascular function including the TcpO 2 were able to discriminate between individuals with and without ulceration, suggesting that such tests may not be of benefit in identifying subjects at greater risk of foot ulceration.
Diabetes Care 27:1343-1348, 2004T he incidence of diabetes-related lower-extremity amputations continues to increase in the developed and developing world; in the U.S., it has been estimated to cost nearly $2 billion and account for 2,600 patient-years of hospital stays per year (1). Up to 80% of these amputations are preceded by foot ulceration (2). Furthermore, between 1995 and 1996, the Medicare costs for patients with foot ulcers were on an average three times higher than those of Medicare patients in general (3). Thus, there is a pressing need for a better understanding of the etiopathogenic factors involved in foot ulceration so that robust screening and preventative measures can be developed.In the absence of macrovascular disease, impaired nerve function and deranged microvascular function have been implicated as important etiological factors (4 -10). With regard to neuropathy, clinical assessment using simple clinical tools such as the neuropathy disability score, neuropathy symptom score, pressure perception using Semmes-Weinstein monofilaments, and vibration sensation with the neurothesiometer (Horwell Scientific Labora...